Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001546271 | SCV001765763 | likely benign | not provided | 2021-06-03 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Labcorp Genetics |
RCV001546271 | SCV002351878 | likely benign | not provided | 2025-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001546271 | SCV004135624 | benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | COL4A1: BS1, BS2 |
Myllykangas group, |
RCV001263180 | SCV001250692 | uncertain significance | Vascular dementia | 2020-04-01 | no assertion criteria provided | research | |
Prevention |
RCV004545051 | SCV004774206 | likely benign | COL4A1-related disorder | 2019-07-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |